Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Akili Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
AKLI
Nasdaq
3845
https://www.akiliinteractive.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Akili Inc
Akili Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
- Mar 3rd, 2024 1:04 pm
Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Feb 29th, 2024 9:01 pm
PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan
- Feb 27th, 2024 7:00 am
Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan
- Feb 26th, 2024 1:47 pm
Akili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updates
- Feb 21st, 2024 9:05 pm
Akili, Inc. (AKLI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
- Jan 15th, 2024 2:55 pm
Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years
- Dec 29th, 2023 1:22 pm
Akili, Inc. (AKLI) Upgraded to Buy: Here's What You Should Know
- Dec 21st, 2023 5:00 pm
EndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17
- Dec 18th, 2023 1:00 pm
Akili, Inc. (NASDAQ:AKLI) Q3 2023 Earnings Call Transcript
- Nov 13th, 2023 2:36 pm
Akili Reports Third Quarter 2023 Financial Results and Provides Business Update
- Nov 9th, 2023 9:02 pm
Akili to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9 at 4:30 p.m. ET
- Oct 19th, 2023 4:27 pm
Employees with ADHD Aren’t Reaching Their Full Potential at Work, Akili Study Finds
- Oct 12th, 2023 12:00 pm
Akili Announces Leadership Transition
- Oct 6th, 2023 11:00 am
Akili Releases EndeavorOTC™ on Android™ Devices, Expanding Treatment Access for Millions of Adults with ADHD
- Sep 21st, 2023 12:00 pm
Insider Sell: CEO Martucci Walter Edward II Sells 2,353 Shares of Akili Inc
- Sep 15th, 2023 7:03 am
Akili Announces Business Transformation, Focusing on Non-prescription Model
- Sep 13th, 2023 12:00 pm
Akili, Inc. (NASDAQ:AKLI) Q2 2023 Earnings Call Transcript
- Aug 14th, 2023 1:26 pm
Q2 2023 Akili Inc Earnings Call
- Aug 11th, 2023 10:43 am
Akili Reports Second Quarter 2023 Financial Results and Provides Business Update
- Aug 10th, 2023 8:01 pm
Scroll